ATE473236T1 - Antigene von piscirickettsia salmonis und deren verwendung - Google Patents

Antigene von piscirickettsia salmonis und deren verwendung

Info

Publication number
ATE473236T1
ATE473236T1 AT04769622T AT04769622T ATE473236T1 AT E473236 T1 ATE473236 T1 AT E473236T1 AT 04769622 T AT04769622 T AT 04769622T AT 04769622 T AT04769622 T AT 04769622T AT E473236 T1 ATE473236 T1 AT E473236T1
Authority
AT
Austria
Prior art keywords
present
discloses
antigens
srs
vaccines
Prior art date
Application number
AT04769622T
Other languages
English (en)
Inventor
Michel Thiry
Ingrid Dheur
Original Assignee
Michel Thiry
Ingrid Dheur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE473236(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Michel Thiry, Ingrid Dheur filed Critical Michel Thiry
Application granted granted Critical
Publication of ATE473236T1 publication Critical patent/ATE473236T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT04769622T 2003-10-07 2004-10-01 Antigene von piscirickettsia salmonis und deren verwendung ATE473236T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20030743 2003-10-07
PCT/IB2004/003339 WO2005035558A2 (en) 2003-10-07 2004-10-01 Piscirickettsia salmonis antigens and use thereof

Publications (1)

Publication Number Publication Date
ATE473236T1 true ATE473236T1 (de) 2010-07-15

Family

ID=34430665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04769622T ATE473236T1 (de) 2003-10-07 2004-10-01 Antigene von piscirickettsia salmonis und deren verwendung

Country Status (9)

Country Link
US (1) US7754223B2 (de)
EP (1) EP1670818B1 (de)
AT (1) ATE473236T1 (de)
AU (1) AU2004279610B2 (de)
CA (1) CA2541464C (de)
DE (1) DE602004028029D1 (de)
DK (1) DK177141B1 (de)
NO (1) NO341223B1 (de)
WO (1) WO2005035558A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615139A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
EP1973406B1 (de) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation Abgabekonstituens für probiotische bakterien umfassend eine trockene matrix aus polysacchariden, sacchariden und polyolen in glasform
DE102007004303A1 (de) * 2006-08-04 2008-02-07 Osram Opto Semiconductors Gmbh Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
DE102007004304A1 (de) * 2007-01-29 2008-07-31 Osram Opto Semiconductors Gmbh Dünnfilm-Leuchtdioden-Chip und Verfahren zur Herstellung eines Dünnfilm-Leuchtdioden-Chips
US7811583B2 (en) 2007-12-19 2010-10-12 Intervet International B.V. Antigens and vaccines against Piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
US9623094B2 (en) * 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
KR101799983B1 (ko) 2009-05-26 2017-12-20 어드밴스드 바이오뉴트리션 코프. 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
NO20100454A1 (no) * 2010-03-26 2011-09-27 Ewos Innovation As Forbindelse og sammensetning for kontroll av bakterier og virus
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
US8420072B2 (en) * 2011-03-24 2013-04-16 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine
WO2013084169A2 (en) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Novel broth medium and blood-free solid media for the culture of the fish pathogen piscirickettsia salmonis
CA2929126C (en) 2013-11-13 2020-01-07 University Of Oslo Outer membrane vesicles and uses thereof
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
CL2017003358A1 (es) * 2017-12-26 2018-06-22 Univ De Chile 50% Formulación de vacuna para peces en base a nanovesículas lipídicas, en especial, un proteoliposoma o cocleato, con actividad contra el síndrome rickettsial del salmón

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
EP0712926B1 (de) 1994-10-18 2003-10-08 Akzo Nobel N.V. Virus, welches die Pankreas-Krankheit bei Fischen verursacht
US20040086524A1 (en) * 1999-09-17 2004-05-06 Kuzyk Michael A. Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
AU3539401A (en) 2000-01-07 2001-07-16 Akzo Nobel N.V. Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish
AU2001240791A1 (en) 2000-03-11 2001-09-24 Novartis Ag Sequence
US6863892B2 (en) * 2000-08-22 2005-03-08 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
CA2428027C (en) 2000-11-11 2012-09-11 The University Court Of The University Of Aberdeen Yeast derived vaccine against ipnv
CA2381708C (en) * 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis

Also Published As

Publication number Publication date
WO2005035558A3 (en) 2005-10-13
EP1670818B1 (de) 2010-07-07
NO20062044L (no) 2006-07-07
DK200600643A (da) 2006-05-05
DE602004028029D1 (en) 2010-08-19
EP1670818A2 (de) 2006-06-21
AU2004279610B2 (en) 2010-02-25
WO2005035558A2 (en) 2005-04-21
AU2004279610A1 (en) 2005-04-21
DK177141B1 (da) 2012-02-06
CA2541464A1 (en) 2005-04-21
US20070207165A1 (en) 2007-09-06
US7754223B2 (en) 2010-07-13
NO341223B1 (no) 2017-09-18
CA2541464C (en) 2016-02-09

Similar Documents

Publication Publication Date Title
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
MXPA05008340A (es) Microbios de vida libre modificados, composiciones de vacuna y metodos de uso de los mismos.
EP1917033A4 (de) Virusähnliche partikel als paramyxovirus-impfstoffe
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
UY26783A1 (es) Antígenos de estreptococo.
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
NO20034244L (no) Mikrobielt fôr for akvakultur og landbruk
MXPA05013526A (es) Secuencias de acido nucleico que codifican y composiciones que comprenden el peptido de senal de ige y/o il-15 y metodos para uso de los mismos.
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
MXPA05005202A (es) Vacuna.
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
EA200970731A1 (ru) Рекомбинантные антигены цитомегаловируса человека (hcmv)
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
ATE520708T1 (de) Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
BR0110278A (pt) Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
DE60143810D1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
CY1109206T1 (el) gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
ATE447968T1 (de) Impfung mit immunisolierten und einen immunomodulator produzierenden zellen
TW200509964A (en) VP1 of foot-and-mouth disease virus
DE602004015141D1 (de) Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe
MX2024005962A (es) Composiciones de proteínas de fusión inmunogénicas y métodos de uso de estas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties